Wasatch Advisors Inc. cut its position in shares of Orthopediatrics Corp (NASDAQ:KIDS) by 24.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 271,064 shares of the company’s stock after selling 86,300 shares during the quarter. Wasatch Advisors Inc.’s holdings in Orthopediatrics were worth $11,989,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of KIDS. RTW Investments LP purchased a new stake in Orthopediatrics during the fourth quarter valued at about $7,848,000. Prospect Capital Advisors LLC purchased a new stake in shares of Orthopediatrics in the fourth quarter worth approximately $7,136,000. American Century Companies Inc. purchased a new stake in shares of Orthopediatrics in the fourth quarter worth approximately $3,880,000. BlackRock Inc. increased its holdings in Orthopediatrics by 18.8% in the third quarter. BlackRock Inc. now owns 405,478 shares of the company’s stock worth $14,856,000 after buying an additional 64,282 shares during the last quarter. Finally, FMR LLC increased its holdings in Orthopediatrics by 8.6% in the fourth quarter. FMR LLC now owns 414,600 shares of the company’s stock worth $14,462,000 after buying an additional 33,000 shares during the last quarter. 44.37% of the stock is owned by institutional investors.

NASDAQ:KIDS traded down $0.18 during mid-day trading on Friday, reaching $39.40. The stock had a trading volume of 1,912 shares, compared to its average volume of 71,770. Orthopediatrics Corp has a fifty-two week low of $19.04 and a fifty-two week high of $47.82. The company has a market capitalization of $602.53 million, a P/E ratio of -40.76 and a beta of 0.04. The company has a debt-to-equity ratio of 0.26, a quick ratio of 6.01 and a current ratio of 8.60.

Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.04). Orthopediatrics had a negative return on equity of 16.43% and a negative net margin of 16.71%. The firm had revenue of $14.66 million during the quarter, compared to analyst estimates of $14.67 million. As a group, sell-side analysts forecast that Orthopediatrics Corp will post -0.45 earnings per share for the current fiscal year.

KIDS has been the topic of a number of research reports. BTIG Research restated a “buy” rating and issued a $44.00 price objective on shares of Orthopediatrics in a report on Friday, May 10th. BidaskClub upgraded Orthopediatrics from a “hold” rating to a “buy” rating in a report on Wednesday, February 20th. Zacks Investment Research upgraded Orthopediatrics from a “hold” rating to a “buy” rating and set a $46.00 price objective on the stock in a report on Saturday, March 16th. Finally, JMP Securities initiated coverage on Orthopediatrics in a report on Wednesday, February 20th. They issued an “outperform” rating and a $44.00 price objective on the stock. One analyst has rated the stock with a sell rating, five have given a buy rating and one has issued a strong buy rating to the company. Orthopediatrics has an average rating of “Buy” and a consensus price target of $41.00.

TRADEMARK VIOLATION WARNING: “Wasatch Advisors Inc. Has $11.99 Million Holdings in Orthopediatrics Corp (KIDS)” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/wasatch-advisors-inc-has-11-99-million-holdings-in-orthopediatrics-corp-kids/3021169.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: What is the Stochastic Momentum Index (SMI)?

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthopediatrics Corp (NASDAQ:KIDS).

Institutional Ownership by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.